Article
Evidence of interaction between humoral immunity and drug half-life in determining…
medRxiv · 2020 · Andagalu, B.; Lu, P.; Onyango, I.; Bergmann-Leitner, E.; Wasuna, R.; Odhiambo, G.; Chebone-Bore, L.; Ingasia, L. A.; Opot, B.; Cheruiyot, A.; Yeda, R.; Okudo, C.; Okoth, R.; Campo, J.; Wallqvist, A.; Akala, H.; Ochiel, D.; Ogutu, B.; Chaudhury, S.; Kamau, E.
Key facts
| Title | Evidence of interaction between humoral immunity and drug half-life in determining treatment outcome for artemisinin combination therapy in high transmission settings in western Kenya |
|---|---|
| First author | Andagalu, B.; Lu, P.; Onyango, I.; Bergmann-Leitner, E.; Wasuna, R.; Odhiambo, G.; Chebone-Bore, L.; Ingasia, L. A.; Opot, B.; Cheruiyot, A.; Yeda, R.; Okudo, C.; Okoth, R.; Campo, J.; Wallqvist, A.; Akala, H.; Ochiel, D.; Ogutu, B.; Chaudhury, S.; Kamau, E. |
| Journal | medRxiv |
| Published | Aug 12, 2020 |
| DOI | 10.1101/2020.08.12.248724 |
| Devices mentioned | K003534, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186 and 6 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, GKZ, JPK and 4 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1